Bio-Rad Laboratories Inc (BIO)
Pretax margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) | US$ in thousands | -850,100 | -4,704,240 | 5,449,060 | 4,918,030 | 2,261,110 |
| Revenue | US$ in thousands | 5,298,670 | 5,562,940 | 5,851,740 | 5,058,790 | 4,601,000 |
| Pretax margin | -16.04% | -84.56% | 93.12% | 97.22% | 49.14% |
December 31, 2023 calculation
Pretax margin = EBT ÷ Revenue
= $-850,100K ÷ $5,298,670K
= -16.04%
Bio-Rad Laboratories Inc.'s pretax margin has exhibited significant fluctuations over the past five years. The company reported negative pretax margins of -31.82% in 2023 and -167.87% in 2022, indicating losses before accounting for taxes. This could be attributed to various factors such as increased expenses or impairment charges.
However, the company showed substantial improvement in its financial performance in 2021 and 2020, with pretax margins of 186.08% and 192.79% respectively. These high margins suggest that Bio-Rad Laboratories Inc. generated significant profits before tax expenses during these years.
In 2019, the company reported a pretax margin of 97.81%, indicating strong profitability levels that year. Overall, the fluctuating pretax margins reflect the company's financial performance volatility and its ability to effectively manage costs and generate profits over the years.
Peer comparison
Dec 31, 2023